Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 2 hrs 29 mins

S&P Futures
3,949.50
+2.50(+0.06%)
Dow Futures
32,085.00
+14.00(+0.04%)
Nasdaq Futures
12,652.00
+7.25(+0.06%)
Russell 2000 Futures
1,746.00
+7.60(+0.44%)
Crude Oil
65.49
-1.25(-1.87%)
Gold
1,982.80
+9.30(+0.47%)

Advertisement

GE HealthCare Technologies Inc. (GEHC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W

75.84

-0.78

(-1.02%)

At close: 04:00PM EDT

75.38

-0.46

(-0.61%)

Pre-Market:

04:00AM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	76.62
Open	76.86
Bid	74.57 x 1000
Ask	79.90 x 800
Day's Range	75.46 - 77.53
52 Week Range	53.00 - 78.76
Volume	5,803,263
Avg. Volume	3,285,371

Market Cap	34.485B
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

All

Yahoo Finance
GE stock has skyrocketed 80% in 5 months — JPMorgan says that's a problem
GE's stock is too richly valued, warns the influential JPM coverage team.
Business Wire
Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services
CINCINNATI & CHICAGO, March 02, 2023--Advantus Health Partners, a health care solutions company delivering more effective, efficient supply chain models to health care organizations, and GE HealthCare (Nasdaq: GEHC), one of the largest providers of medical equipment maintenance services in the world, announced an agreement of up to $760M over 10-years to provide GE HealthCare’s Healthcare Technology Management (HTM) services to Advantus Health Partners’ clients.
Business Wire
GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
CHALFONT ST GILES, England, March 01, 2023--Phase I Completion for Early Clinical Development Program for First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

Advertisement

S&P Futures3,949.50+2.50(+0.06%)

Dow Futures32,085.00+14.00(+0.04%)

Nasdaq Futures12,652.00+7.25(+0.06%)

Russell 2000 Futures1,746.00+7.60(+0.44%)

Crude Oil65.49-1.25(-1.87%)

Gold1,982.80+9.30(+0.47%)

GE HealthCare Technologies Inc. (GEHC)

Chart Events

Performance Outlook

GE stock has skyrocketed 80% in 5 months — JPMorgan says that's a problem

Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

S&P Futures
3,949.50
+2.50(+0.06%)

Dow Futures
32,085.00
+14.00(+0.04%)

Nasdaq Futures
12,652.00
+7.25(+0.06%)

Russell 2000 Futures
1,746.00
+7.60(+0.44%)

Crude Oil
65.49
-1.25(-1.87%)

Gold
1,982.80
+9.30(+0.47%)